Product Code: GVR-4-68039-805-9
Sacroiliac Joint Fusion Market Growth & Trends:
The global sacroiliac joint fusion market size is expected to reach USD 2.49 billion by 2030, according to a new report by Grand View Research, Inc.It is expected to expand at a CAGR of 19.8% from 2024 to 2030. Key market players are investing substantially in Research & Development (R&D) activities to create innovative and effective devices. This increase in R&D activities is expected to drive market growth over the coming years. In addition, the market is expected to grow further due to the increasing prevalence of bone disorders and ongoing technological advancements.
Increasing prevalence of lower back, buttock, groin, and lower extremity pain drives SI joint fusion market growth. These chronic and debilitating forms of pain have become alarmingly common, affecting a substantial portion of the global population. This trend poses significant challenges to healthcare systems and fuels demand for innovative solutions to alleviate suffering and restore mobility. Chronic pain in the lower back, buttock, groin, and lower extremity represents a significant portion of SI joint disorder cases, comprising 10% to 26% of such cases, as the Centers for Medicare & Medicaid Services reported in December 2021. The prevalence of symptoms associated with SI joint disorders highlights their substantial healthcare challenge.
In addition, a factor propelling market growth is the increasing use of innovative materials and technologies to develop improved and safer SI joint fusion systems. For instance, in October 2022, Aurora Spine, a company specializing in regenerative technologies focusing on minimally invasive approaches, announced that it had received 510(k) clearance from the U.S. FDA for its patented SiLO TFX MIS. The SI joint fixation system is a minimally invasive solution intended for SI joint fusion in cases involving SI joint disruptions and degenerative sacroiliitis. The SiLO TFX system comprises an ilium screw, sacrum screw, associated instrumentation, and transfixing cone designed to achieve fixation and stability for bony fusion between the sacrum and ilium. Thus, such technological advancements are expected to boost market growth.
North America dominated the market with the largest revenue share in 2023. North America is the leading market for upper limb prosthetics across the globe. The dominance can be attributed to advanced healthcare infrastructure, the presence of key companies, and growing reimbursement coverage. Key market players are involved in implementing strategic initiatives, such as conducting clinical tests of their products, regional expansion, patent applications, product launches, and partnerships & collaborations to increase their market share.
Sacroiliac Joint Fusion Market Report Highlights:
- By indication, the degenerative sacroiliitis segment accounted for the largest revenue share of 38.6% in 2023. Growing awareness about the condition and improving diagnostic capabilities for sacroiliac joint disorders are among the major factors that drive the growth of the segment.
- By treatment type, surgery segment dominated the market in terms of revenue share in 2023. Its dominance is attributed to the growing preference for minimally invasive surgeries, driven by their advantages, including smaller incisions, decreased pain & scarring, and quicker recovery periods.
- By end user, the hospitals segment dominated the market in 2023. Hospitals offer specialized, extended care for patients, and their treatments are frequently eligible for reimbursement, further fostering their adoption.
- North America dominated the market with the largest revenue share in 2023 owing to well-established healthcare infrastructure and increasing R&D investments by companies.
- Asia Pacific region is expected to grow at the fastest rate during the forecast period, owing to the presence of a large patient pool, developing healthcare facilities, and investments by key companies in this region.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Technology
- 1.1.2. Treatment
- 1.1.3. Application
- 1.1.4. Regional scope
- 1.1.5. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.3.5.1. Data for primary interviews in North America
- 1.3.5.2. Data for primary interviews in Europe
- 1.3.5.3. Data for primary interviews in Asia Pacific
- 1.3.5.4. Data for primary interviews in Latin America
- 1.3.5.5. Data for Primary interviews in MEA
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.2. Approach 1: Commodity flow approach
- 1.6.3. Volume price analysis (Model 2)
- 1.6.4. Approach 2: Volume price analysis
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Technology outlook
- 2.2.2. Treatment outlook
- 2.2.3. Application outlook
- 2.2.4. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Sacroiliac Joint Fusion Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Increasing prevalence of lower back, buttock, groin, and lower extremity pain
- 3.2.1.2. Technological advancements
- 3.2.1.3. Growing cases of Sacroiliitis or Sacroiliac joint dysfunction
- 3.2.2. Market restraint analysis
- 3.2.2.1. Lack of awareness
- 3.3. Sacroiliac Joint Fusion Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
Chapter 4. Sacroiliac Joint Fusion Market: Indication Estimates & Trend Analysis
- 4.1. Definitions and Scope
- 4.1.1. Degenerative sacroiliitis
- 4.1.2. Sacral disruption
- 4.1.3. Trauma
- 4.2. Indication Market Share, 2023 & 2030
- 4.3. Segment Dashboard
- 4.4. Global Sacroiliac Joint Fusion Market by Indication Outlook
- 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 4.5.1. Degenerative sacroiliitis
- 4.5.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 4.5.2. Sacral disruption
- 4.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 4.5.3. Trauma
- 4.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Sacroiliac Joint Fusion Market: Treatment Type Estimates & Trend Analysis
- 5.1. Definitions and Scope
- 5.1.1. Surgery
- 5.1.2. Injections
- 5.1.3. RF ablation
- 5.2. Treatment Type Market Share, 2023 & 2030
- 5.3. Segment Dashboard
- 5.4. Global Sacroiliac Joint Fusion Market by Treatment Type Outlook
- 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 5.5.1. Surgery
- 5.5.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 5.5.2. Injections
- 5.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 5.5.3. RF ablation
- 5.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Sacroiliac Joint Fusion Market: End User Estimates & Trend Analysis
- 6.1. Definitions and Scope
- 6.1.1. Hospitals
- 6.1.2. Ambulatory Surgical Centers
- 6.1.3. Others
- 6.2. End user Market Share, 2023 & 2030
- 6.3. Segment Dashboard
- 6.4. Global Sacroiliac Joint Fusion Market by End User Outlook
- 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 6.5.1. Hospitals
- 6.5.1.1. Market estimates and forecast 2018 to 2030 (USD million)
- 6.5.2. Ambulatory surgical centers
- 6.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 6.5.3. Others
- 6.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. Sacroiliac Joint Fusion Market: Regional Estimates & Trend Analysis
- 7.1. Regional Market Share Analysis, 2023 & 2030
- 7.2. Regional Market Dashboard
- 7.3. Global Regional Market Snapshot
- 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
- 7.5. North America
- 7.5.1. U.S.
- 7.5.1.1. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
- 7.5.2. Canada
- 7.5.2.1. Canada market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6. Europe
- 7.6.1. UK
- 7.6.1.1. UK market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.2. Germany
- 7.6.2.1. Germany market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.3. France
- 7.6.3.1. France market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.4. Italy
- 7.6.4.1. Italy market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.5. Spain
- 7.6.5.1. Spain market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.6. Norway
- 7.6.6.1. Norway market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.7. Sweden
- 7.6.7.1. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.8. Denmark
- 7.6.8.1. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
- 7.7. Asia Pacific
- 7.7.1. Japan
- 7.7.1.1. Japan market estimates and forecast, 2018 - 2030 (USD Million)
- 7.7.2. China
- 7.7.2.1. China market estimates and forecast, 2018 - 2030 (USD Million)
- 7.7.3. India
- 7.7.3.1. India market estimates and forecast, 2018 - 2030 (USD Million)
- 7.7.4. Australia
- 7.7.4.1. Australia market estimates and forecast, 2018 - 2030 (USD Million)
- 7.7.5. South Korea
- 7.7.5.1. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
- 7.7.6. Thailand
- 7.7.6.1. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
- 7.8. Latin America
- 7.8.1. Brazil
- 7.8.1.1. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
- 7.8.2. Mexico
- 7.8.2.1. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
- 7.8.3. Argentina
- 7.8.3.1. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
- 7.9. MEA
- 7.9.1. South Africa
- 7.9.1.1. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
- 7.9.2. Saudi Arabia
- 7.9.2.1. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
- 7.9.3. UAE
- 7.9.3.1. UAE market estimates and forecast, 2018 - 2030 (USD Million)
- 7.9.4. Kuwait
- 7.9.4.1. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Company/Competition Categorization
- 8.3. Vendor Landscape
- 8.3.1. List of key distributors and channel partners
- 8.3.2. Key customers
- 8.3.3. Key company market share analysis, 2023
- 8.3.4. SI-BONE, Inc.
- 8.3.4.1. Company overview
- 8.3.4.2. Financial performance
- 8.3.4.3. Product benchmarking
- 8.3.4.4. Strategic initiatives
- 8.3.5. PainTEQ
- 8.3.5.1. Company overview
- 8.3.5.2. Financial performance
- 8.3.5.3. Product benchmarking
- 8.3.5.4. Strategic initiatives
- 8.3.6. CornerLoc
- 8.3.6.1. Company overview
- 8.3.6.2. Financial performance
- 8.3.6.3. Product benchmarking
- 8.3.6.4. Strategic initiatives
- 8.3.7. SIGNUS Medizintechnik GmbH
- 8.3.7.1. Company overview
- 8.3.7.2. Financial performance
- 8.3.7.3. Product benchmarking
- 8.3.7.4. Strategic initiatives
- 8.3.8. Globus Medical
- 8.3.8.1. Company overview
- 8.3.8.2. Financial performance
- 8.3.8.3. Product benchmarking
- 8.3.8.4. Strategic initiatives
- 8.3.9. Orthofix Medical, Inc.
- 8.3.9.1. Company overview
- 8.3.9.2. Financial performance
- 8.3.9.3. Product benchmarking
- 8.3.9.4. Strategic initiatives
- 8.3.10. Life Spine, Inc.
- 8.3.10.1. Company overview
- 8.3.10.2. Financial performance
- 8.3.10.3. Product benchmarking
- 8.3.10.4. Strategic initiatives
- 8.3.11. Camber Spine Technologies, LLC
- 8.3.11.1. Company overview
- 8.3.11.2. Financial performance
- 8.3.11.3. Product benchmarking
- 8.3.11.4. Strategic initiatives
- 8.3.12. CoreLink Surgical
- 8.3.12.1. Company overview
- 8.3.12.2. Financial performance
- 8.3.12.3. Product benchmarking
- 8.3.12.4. Strategic initiatives
- 8.3.13. Xtant Medical
- 8.3.13.1. Company overview
- 8.3.13.2. Financial performance
- 8.3.13.3. Product benchmarking
- 8.3.13.4. Strategic initiatives
- 8.3.14. Surgalign Spine Technologies, Inc.
- 8.3.14.1. Company overview
- 8.3.14.2. Financial performance
- 8.3.14.3. Product benchmarking
- 8.3.14.4. Strategic initiatives
- 8.3.15. Medtronic
- 8.3.15.1. Company overview
- 8.3.15.2. Financial performance
- 8.3.15.3. Product benchmarking
- 8.3.15.4. Strategic initiatives